LIN28B and breast neoplasm: Limiting dilution assays confirmed the increased in vivo tumorigenic capacity of Lin28B-expressing 4TO7 tumors (Supplementary Fig. 1p), suggesting that Lin28B facilitates the stem cell properties of breast tumor cells.